Pharmaceutical Excipients Market Share, Size, Trends, Industry Analysis Report, By Product (Inorganic Chemicals, Organic Chemicals); By Formulation; By Functionality; By Region; Segment Forecast, 2023 - 2032

Pharmaceutical Excipients Market Share, Size, Trends, Industry Analysis Report, By Product (Inorganic Chemicals, Organic Chemicals); By Formulation; By Functionality; By Region; Segment Forecast, 2023 - 2032

The global pharmaceutical excipients market size is expected to reach USD 16.79 Billion by 2032, according to a new study by Polaris Market Research. The report “Pharmaceutical Excipients Market Share, Size, Trends, Industry Analysis Report, By Product (Inorganic Chemicals, Organic Chemicals); By Formulation; By Functionality; By Region; Segment Forecast, 2024 - 2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Pharmaceutical excipients are included in pharmaceutical formulations not primarily for their therapeutic benefits but instead to streamline the manufacturing process, safeguard the product, enhance its stability, improve bioavailability, and ensure patient acceptance. Furthermore, they can contribute to product identification and play a crucial role in maintaining the product's safety and functionality during storage and use.

Pharmaceutical excipients are essential for optimizing the drug administration process, fostering adherence to dosing regimens, preserving consistency, stabilizing active pharmaceutical components, modulating drug absorption, and guaranteeing the dependability and uniformity of the end product.

Surging levels of investment in research and development (R&D) are propelling the expansion of the market. Pharmaceutical companies are dedicating significant resources to R&D projects focused on creating medications that are both more efficient and safer. Excipients are essential in enhancing the effectiveness and safety of medication formulations during this process. As R&D spending continues to increase, there is an expected growth in the need for innovative and high-quality excipients.

The pharmaceutical sector experienced substantial changes as a result of the far-reaching consequences of the COVID-19 pandemic. The imposition of lockdowns in response to the outbreak disrupted the flow of crucial raw materials obtained from major production centers such as India and China. As a result, this disruption had a negative impact on the advancement of drug research and production procedures, especially affecting companies that heavily depend on external suppliers. In the beginning, the pandemic caused significant turmoil throughout the pharmaceutical industry as a whole.

During the COVID-19 pandemic, pharmaceutical and biotech companies exhibited remarkable resilience and ingenuity in crafting therapeutics, vaccines, and scientific approaches. Additionally, regulatory agencies were prompted to reevaluate and implement new guidelines to guarantee the well-being of patients using pharmaceutical treatments.

Additionally, a study published in the National Library of Medicine in June 2021 highlighted the significant impact of coronary artery disease (CAD) on global health. CAD alone is responsible for approximately 610,000 deaths annually, accounting for an estimated one in four deaths and making it the foremost cause of mortality in the United States. With the incidence of CAD rising, there is a growing demand for effective coronary stent devices to address this pressing medical need. Consequently, this factor is projected to drive the demand for coronary stents throughout the forecast period.

Pharmaceutical Excipients Market Report Highlights

In 2022, the Organic Chemicals segment held the largest revenue share in the Pharmaceutical Excipients Market. The Global Pharmaceutical Excipients Market is poised for substantial expansion in the coming years, primarily due to the prevalence of compounds used in pharmaceutical formulations. This growth is underpinned by the increasing demand for drug manufacturing that relies on natural resources and minimizes adverse side effects. Furthermore, the life sciences industry is witnessing a surge in the utilization of HPMC organic compounds, further propelling the growth of this specific sector. The market also stands to gain from factors like the widespread adoption of derivatives in solid oral dosage forms and the continual advancements in global generic product development.

The Blinders segment accounted for the largest market share during the forecast period. Binder excipients play a pivotal role in pharmaceutical formulations by acting as essential adhesives, effectively uniting powders, granules, and other dry components to provide structural integrity to pharmaceutical products. Moreover, these excipients hold significant importance in drug formulation by augmenting drug volume, promoting disintegration, and expediting dissolution rates. Consequently, the pharmaceutical industry is experiencing a growing demand for these excipients in the manufacturing of drugs and medicines. As the prevalence of illnesses and medical conditions continues to rise, there is an amplified need for medications and treatments. This increased demand for pharmaceuticals is creating a higher requirement for binder excipients that are indispensable in the production of medical drugs. This, in turn, is expected to be a driving force behind market growth in the coming years.

In 2022, Asia-Pacific dominated the largest market. A recent study reveals that the traditional pharmaceutical industry in China generated approximately $28.8 billion in sales revenue. This sector is poised for continued growth in the foreseeable future. India also holds a prominent position in the global pharmaceutical landscape, serving as the source of over 50% of the world's vaccines, 40% of the United States' generic drug supply, and 25% of all medications for the United Kingdom, particularly during the ongoing COVID-19 pandemic. Furthermore, India boasts the world's second-largest pharmaceutical and biotech workforce. According to the Indian Economic Survey of 2021, the domestic pharmaceutical market is expected to triple in size over the next decade.

The Europe region accounted for the fastest growth in the Pharmaceuticals Excipients Market. The region is currently witnessing a substantial increase in the use of excipients. This surge can be attributed primarily to the emergence of major pharmaceutical giants equipped with extensive manufacturing capabilities. Furthermore, this heightened the growing requirement for innovative excipient components, which drives demand for excipients. The pharmaceutical industry is increasingly reliant on advanced pharmaceutical drugs, generic medications, and biosimilar products.

Several factors have influenced this market. These include the ongoing development of new drugs, the expansion of the generic drug sector, and a notable emphasis on patient-friendly formulations. Such formulations include oral dissolvable tablets and excipients designed to mask taste. It's worth noting that the European Medicines Agency (EMA) plays a crucial role in ensuring product safety and regulatory compliance within this context.

The global key market players include Ashland Inc., Associated British Foods Plc, BASF SE, Croda International Inc., DOW Chemical Company, DuPont de Nemours Inc., Evonik Industries AG, FMG Corporation, Innophos Holdings Inc., Lubrizol Corporation, MEGGLE Excipients & Technology, and Roquette Group

Polaris Market Research has segmented the pharmaceutical excipients market report based on product, formulation, functionality, and region:

Pharmaceutical Excipients, Product Outlook (Revenue - USD Billion, 2019 - 2032)

Inorganic Chemicals

Organic Chemicals

Pharmaceuticals Excipients, Formulation Outlook (Revenue - USD Billion, 2019 - 2032)

Tablets Formulation

Capsules Formulation

Parental Formulation

Liquid Formulation

Oral Formulation

Pharmaceutical Excipients, Functionality Outlook (Revenue - USD Billion, 2019 - 2032)

Blinders

Fillers & Diluents

Suspending & Viscosity agents

Preservatives

Flavoring agents & Sweeteners

Coating agents

Coronary Stent, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

North America

U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Latin America

Argentina

Brazil

Mexico

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa